Skip to main content

Clinical Trials › NCT06220669

Active, Not RecruitingPhase 2

A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis

Sponsored by Eli Lilly and Company

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
63
Target enrollment
5
U.S. states
Mar 2024
Start date
Jul 2026
Expected completion

Interventions / Treatments

LY3541860Placebo

Conditions studied

Multiple Sclerosis

Where this trial is running (6 sites)

Florida2 sites
Gulf Breeze · Winter Park
Illinois1 site
Northbrook
Missouri1 site
Ozark
Greer
Tennessee1 site
Knoxville

Participating MS centers on MS Buddy (2)

Premier Neurology, PC
Greenville, SC

MS centers in Florida

Compare treatment centers near a trial site by center type, providers and trials.

View Florida centers

More Phase 2 trials

Browse all Phase 2 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play